AFT Pharmaceuticals Limited (NZE:AFT)
New Zealand · Delayed Price · Currency is NZD 3.680
+0.030 (0.82%)
Jun 22, 2026, 4:59 PM NZST
AFT Pharmaceuticals Ratios and Metrics
Market cap in millions NZD. Fiscal year is April - March.
Millions NZD. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 18, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 386 | 352 | 282 | 328 | 363 | 378 | |
Market Cap Growth | 30.50% | 24.91% | -14.06% | -9.54% | -4.00% | -26.99% |
Enterprise Value | 429 | 377 | 305 | 363 | 395 | 414 |
Last Close Price | 3.68 | 3.33 | 2.65 | 3.07 | 3.38 | 3.53 |
PE Ratio | 26.29 | 23.92 | 23.58 | 21.03 | 34.06 | 19.04 |
Forward PE | 19.58 | 18.37 | 16.79 | 19.41 | 19.12 | 18.43 |
PS Ratio | 1.52 | 1.38 | 1.36 | 1.68 | 2.32 | 2.90 |
PB Ratio | 3.54 | 3.23 | 2.91 | 3.74 | 4.95 | 6.07 |
P/TBV Ratio | 4.16 | 3.80 | 3.51 | 4.47 | 6.35 | 8.16 |
P/FCF Ratio | - | - | 21.88 | 11.42 | 31.74 | 27.34 |
P/OCF Ratio | - | - | 21.41 | 11.37 | 31.20 | 26.71 |
PEG Ratio | 0.55 | 0.51 | 0.82 | 0.54 | 1.61 | 0.38 |
EV/Sales Ratio | 1.68 | 1.48 | 1.47 | 1.86 | 2.52 | 3.18 |
EV/EBITDA Ratio | 16.65 | 15.16 | 16.92 | 14.74 | 19.89 | 20.04 |
EV/EBIT Ratio | 17.53 | 15.42 | 17.27 | 14.98 | 20.10 | 20.31 |
EV/FCF Ratio | - | - | 23.64 | 12.63 | 34.58 | 29.96 |
Debt / Equity Ratio | 0.50 | 0.50 | 0.31 | 0.37 | 0.52 | 0.65 |
Debt / EBITDA Ratio | 2.10 | 2.10 | 1.59 | 1.27 | 1.85 | 1.90 |
Debt / FCF Ratio | - | - | 2.33 | 1.12 | 3.33 | 2.93 |
Net Debt / Equity Ratio | 0.40 | 0.40 | 0.20 | 0.23 | 0.45 | 0.52 |
Net Debt / EBITDA Ratio | 1.76 | 1.76 | 1.05 | 0.82 | 1.68 | 1.58 |
Net Debt / FCF Ratio | -4.54 | -4.54 | 1.47 | 0.70 | 2.91 | 2.36 |
Asset Turnover | 1.32 | 1.32 | 1.24 | 1.25 | 1.14 | 1.12 |
Inventory Turnover | 2.35 | 2.35 | 2.38 | 2.34 | 2.21 | 2.04 |
Quick Ratio | 1.03 | 1.03 | 1.25 | 1.15 | 1.12 | 1.30 |
Current Ratio | 2.24 | 2.24 | 2.51 | 2.30 | 2.38 | 2.67 |
Return on Equity (ROE) | 13.66% | 13.66% | 12.33% | 19.38% | 15.72% | 40.14% |
Return on Assets (ROA) | 7.90% | 7.90% | 6.58% | 9.67% | 8.93% | 10.96% |
Return on Invested Capital (ROIC) | 10.29% | 11.70% | 11.21% | 16.02% | 13.17% | 23.92% |
Return on Capital Employed (ROCE) | 16.20% | 16.20% | 13.90% | 20.30% | 18.20% | 20.70% |
Earnings Yield | 3.82% | 4.18% | 4.24% | 4.75% | 2.94% | 5.25% |
FCF Yield | -2.50% | -2.74% | 4.57% | 8.76% | 3.15% | 3.66% |
Dividend Yield | 0.68% | 0.75% | 0.68% | 0.52% | 0.33% | - |
Payout Ratio | 12.81% | 12.81% | 14.03% | 7.39% | - | - |
Buyback Yield / Dilution | - | - | - | -0.02% | -0.16% | -1.34% |
Total Shareholder Return | 0.68% | 0.75% | 0.68% | 0.50% | 0.17% | -1.34% |